Puma Biotechnology Dividends
| PBYI Stock | USD 6.48 0.05 0.78% |
The Puma Biotechnology's current Dividend Paid And Capex Coverage Ratio is estimated to increase to 656.74. Puma Biotechnology's past performance could be the main factor of why investors trade Puma Biotechnology stock today. Investors should clearly understand every aspect of the Puma Biotechnology dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Puma Biotechnology's dividend schedule and payout information. Puma Biotechnology dividends can also provide a clue to the current valuation of Puma Biotechnology.
| Last Reported | Projected for Next Year | ||
| Dividend Paid And Capex Coverage Ratio | 625.47 | 656.74 |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Puma Biotechnology must own a stock before its ex-dividend date to receive its next dividend.
Is there potential for Biotechnology market expansion? Will Puma introduce new products? Factors like these will boost the valuation of Puma Biotechnology. Anticipated expansion of Puma directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Puma Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.58) | Earnings Share 0.74 | Revenue Per Share | Quarterly Revenue Growth (0.32) | Return On Assets |
The market value of Puma Biotechnology is measured differently than its book value, which is the value of Puma that is recorded on the company's balance sheet. Investors also form their own opinion of Puma Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Puma Biotechnology's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Puma Biotechnology's market value can be influenced by many factors that don't directly affect Puma Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Puma Biotechnology's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Puma Biotechnology should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Puma Biotechnology's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.